Payment overview · 2025
General Payments
$46.39
2 reported records · 2 companies
Healthcare provider profile · identity verified
Melissa Weckesser, MD
Allopathic & Osteopathic Physicians|Family Medicine · MIDLAND, MI · NPI 1588078620
Verified facts
What the public records show
CMS Open Payments records show Melissa Weckesser, MD received $46.39 in general payments during 2025 across 2 reported records.
Inspire Medical Systems, Inc. accounted for 57.2% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Inspire Medical Systems, Inc. | Unresolved — no canonical attribution shown | $26.55 | 57.2% | 1 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $19.84 | 42.8% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $46.39 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| INSPIRE Normalized: inspire |
Device | Inspire Medical Systems, Inc. | $26.55 | 1 | 2025 |
Source payment records
|
|||||
| Cologuard Collection Kit Normalized: cologuard collection kit |
Device | Exact Sciences Corporation | $19.84 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 703 | 199 |
| Levothyroxine Sodium | Levothyroxine Sodium | 462 | 119 |
| Lisinopril | Lisinopril | 448 | 128 |
| Amlodipine Besylate | Amlodipine Besylate | 354 | 100 |
| Gabapentin | Gabapentin | 292 | 62 |
| Omeprazole | Omeprazole | 224 | 66 |
| Hydrochlorothiazide | Hydrochlorothiazide | 195 | 58 |
| Losartan Potassium | Losartan Potassium | 195 | 57 |
| Simvastatin | Simvastatin | 186 | 48 |
| Sertraline Hcl | Sertraline Hcl | 175 | 51 |
| Metformin Hcl | Metformin Hcl | 164 | 47 |
| Pantoprazole Sodium | Pantoprazole Sodium | 162 | 48 |
| Alendronate Sodium | Alendronate Sodium | 159 | 40 |
| Mounjaro | Tirzepatide | 146 | 31 |
| Tamsulosin Hcl | Tamsulosin Hcl | 144 | 38 |
| Buspirone Hcl | Buspirone Hcl | 141 | 38 |
| Trazodone Hcl | Trazodone Hcl | 139 | 38 |
| Pravastatin Sodium | Pravastatin Sodium | 136 | 35 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 128 | 25 |
| Tramadol Hcl | Tramadol Hcl | 127 | 27 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 125 | 52 |
| Montelukast Sodium | Montelukast Sodium | 121 | 32 |
| Meloxicam | Meloxicam | 109 | 39 |
| Eliquis | Apixaban | 107 | 28 |
| Metoprolol Tartrate | Metoprolol Tartrate | 105 | 34 |
| Fluticasone Propionate | Fluticasone Propionate | 104 | 31 |
| Ropinirole Hcl | Ropinirole Hcl | 102 | 22 |
| Pregabalin | Pregabalin | 100 | 21 |
| Famotidine | Famotidine | 96 | 34 |
| Donepezil Hcl | Donepezil Hcl | 93 | 27 |
| Glipizide | Glipizide | 89 | 22 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 81 | 30 |
| Duloxetine Hcl | Duloxetine Hcl | 78 | 21 |
| Ozempic | Semaglutide | 77 | 17 |
| Alprazolam | Alprazolam | 73 | 18 |
| Metoprolol Succinate | Metoprolol Succinate | 72 | 26 |
| Fenofibrate | Fenofibrate Nanocrystallized | 70 | 20 |
| Fluoxetine Hcl | Fluoxetine Hcl | 69 | 17 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 67 | 15 |
| Fenofibrate | Fenofibrate | 65 | 14 |
| Furosemide | Furosemide | 65 | 26 |
| Citalopram Hbr | Citalopram Hydrobromide | 63 | 19 |
| Warfarin Sodium | Warfarin Sodium | 63 | 14 |
| Fenofibrate | Fenofibrate,micronized | 62 | 12 |
| Zolpidem Tartrate | Zolpidem Tartrate | 55 | suppressed |
| Bupropion Xl | Bupropion Hcl | 54 | 15 |
| Celecoxib | Celecoxib | 54 | 18 |
| Tizanidine Hcl | Tizanidine Hcl | 54 | 23 |
| Carvedilol | Carvedilol | 53 | 14 |
| Memantine Hcl | Memantine Hcl | 53 | 16 |
| Atenolol | Atenolol | 52 | 17 |
| Baclofen | Baclofen | 52 | 17 |
| Potassium Chloride | Potassium Chloride | 52 | 17 |
| Clopidogrel | Clopidogrel Bisulfate | 50 | 15 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 49 | 20 |
| Trulicity | Dulaglutide | 48 | 13 |
| Allopurinol | Allopurinol | 44 | 16 |
| Clonazepam | Clonazepam | 41 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 41 | 12 |
| Metformin Hcl Er | Metformin Hcl | 40 | 11 |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 39 | 15 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 38 | suppressed |
| Ezetimibe | Ezetimibe | 38 | 15 |
| Levetiracetam | Levetiracetam | 38 | suppressed |
| Ibuprofen | Ibuprofen | 37 | 19 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 37 | 11 |
| Xarelto | Rivaroxaban | 37 | 12 |
| Temazepam | Temazepam | 36 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 35 | suppressed |
| Synthroid | Levothyroxine Sodium | 35 | 11 |
| Glimepiride | Glimepiride | 34 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 33 | 11 |
| Ventolin Hfa | Albuterol Sulfate | 33 | 15 |
| Glipizide Er | Glipizide | 32 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 30 | suppressed |
| Cephalexin | Cephalexin | 29 | 24 |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 29 | 12 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 28 | suppressed |
| Lansoprazole | Lansoprazole | 28 | suppressed |
| Spironolactone | Spironolactone | 28 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 28 | 16 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 28 | suppressed |
| Januvia | Sitagliptin Phosphate | 27 | suppressed |
| Prednisone | Prednisone | 27 | 22 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 25 | 24 |
| Clonidine Hcl | Clonidine Hcl | 25 | 12 |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 25 | suppressed |
| Estradiol | Estradiol | 24 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 24 | suppressed |
| Lorazepam | Lorazepam | 24 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 23 | suppressed |
| Nystatin | Nystatin | 23 | 12 |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 23 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 23 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 23 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 22 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 22 | suppressed |
| Methylprednisolone | Methylprednisolone | 21 | 21 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 21 | suppressed |
| Bumetanide | Bumetanide | 20 | suppressed |
| Jardiance | Empagliflozin | 20 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 19 | suppressed |
| Diazepam | Diazepam | 19 | suppressed |
| Lovastatin | Lovastatin | 19 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 19 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 19 | suppressed |
| Azithromycin | Azithromycin | 18 | 17 |
| Prazosin Hcl | Prazosin Hcl | 17 | suppressed |
| Vilazodone Hcl | Vilazodone Hcl | 17 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 16 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 16 | suppressed |
| Acyclovir | Acyclovir | 15 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 15 | suppressed |
| Sucralfate | Sucralfate | 15 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 14 | suppressed |
| Finasteride | Finasteride | 14 | suppressed |
| Gemfibrozil | Gemfibrozil | 14 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 14 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 14 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 14 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 14 | 14 |
| Valsartan | Valsartan | 14 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 13 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 13 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 13 | 12 |
| Propranolol Hcl Er | Propranolol Hcl | 13 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 13 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 12 | suppressed |
| Carbamazepine Er | Carbamazepine | 12 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 12 | suppressed |
| Lactulose | Lactulose | 12 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 12 | suppressed |
| Nifedipine Er | Nifedipine | 12 | suppressed |
| Novolog Flexpen | Insulin Aspart | 12 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 12 | suppressed |
| Topiramate | Topiramate | 12 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 11 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 11 | suppressed |
| Bydureon Bcise | Exenatide Microspheres | 11 | suppressed |
| Metronidazole | Metronidazole | 11 | suppressed |
| Nystatin-Triamcinolone | Nystatin/Triamcinolone Acet | 11 | suppressed |
| Ondansetron Odt | Ondansetron | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $46.39 · 2 records | Inspire Medical Systems, Inc. | Cologuard Collection Kit, INSPIRE | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error